Polygenic Score (PGS) ID: PGS000904

Predicted Trait
Reported Trait PR interval
Mapped Trait(s) PR interval (EFO_0004462)
Released in PGS Catalog: Sept. 17, 2021
Download Score FTP directory
Terms and Licenses
PGS obtained from the Catalog should be cited appropriately, and used in accordance with any licensing restrictions set by the authors. See EBI Terms of Use (https://www.ebi.ac.uk/about/terms-of-use/) for additional details.

Score Details

Score Construction
PGS Name PRS582_PR
Development Method
Name Clumping and Thresholding (C+T)
Parameters r^2 = 0.1 in a 250kb region, p = 5e-8, imputation quality > 0.6
Variants
Original Genome Build GRCh37
Number of Variants 582
Effect Weight Type beta
PGS Source
PGS Catalog Publication (PGP) ID PGP000236
Citation (link to publication) Ntalla I et al. Nat Commun (2020)
Ancestry Distribution
Source of Variant
Associations (GWAS)
European: 100%
271,570 individuals (100%)
PGS Evaluation
European: 100%
8 Sample Sets

Development Samples

Source of Variant Associations (GWAS)
Study Identifiers Sample Numbers Sample Ancestry Cohort(s)
GWAS Catalog: GCST010320
Europe PMC: 32439900
271,570 individuals European 34 cohorts
  • AGES
  • ,AMISH
  • ,ARIC
  • ,BRIGHT
  • ,BioMe
  • ,CHRIS
  • ,CHS
  • ,CROATIA-KORCULA
  • ,CROATIA-SPLIT
  • ,ERF
  • ,FHS
  • ,FINCAVAS
  • ,GS:SFHS
  • ,Health2000
  • ,INGI-Carlantino
  • ,INGI-FVG
  • ,KORA
  • ,LifeLines
  • ,MESA
  • ,MICROS
  • ,NEO
  • ,ORCADES
  • ,PIVUS
  • ,PREVEND
  • ,PROSPER
  • ,RS
  • ,SHIP
  • ,SardiNIA
  • ,TwinsUK
  • ,UKB
  • ,ULSAM
  • ,WHI
  • ,YFS
  • ,deCODE

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM002666 PSS001175|
European Ancestry|
309,269 individuals
PGP000236 |
Ntalla I et al. Nat Commun (2020)
Reported Trait: Atrial fibrillation OR: 0.95
β: -0.047 (0.009)
Baseline age, sex, genotyping array, trait-related principal components Only 581 SNPs from the 582 SNP PRS were utilised. 1 SNP was not included due to low imputation quality.
PPM002667 PSS001178|
European Ancestry|
290,252 individuals
PGP000236 |
Ntalla I et al. Nat Commun (2020)
Reported Trait: Distal conduction disease OR: 1.11
β: 0.103 (0.019)
Baseline age, sex, genotyping array, trait-related principal components Only 581 SNPs from the 582 SNP PRS were utilised. 1 SNP was not included due to low imputation quality.
PPM002668 PSS001176|
European Ancestry|
309,041 individuals
PGP000236 |
Ntalla I et al. Nat Commun (2020)
Reported Trait: Atrioventricular preexcitation OR: 0.85
β: -0.168 (0.057)
Baseline age, sex, genotyping array, trait-related principal components Only 581 SNPs from the 582 SNP PRS were utilised. 1 SNP was not included due to low imputation quality.
PPM002669 PSS001179|
European Ancestry|
309,241 individuals
PGP000236 |
Ntalla I et al. Nat Commun (2020)
Reported Trait: Implantable cardioverter defibrillator OR: 1.09
β: 0.086 (0.04)
Baseline age, sex, genotyping array, trait-related principal components Only 581 SNPs from the 582 SNP PRS were utilised. 1 SNP was not included due to low imputation quality.
PPM002670 PSS001180|
European Ancestry|
309,246 individuals
PGP000236 |
Ntalla I et al. Nat Commun (2020)
Reported Trait: Mitral valve prolapse OR: 1.1
β: 0.093 (0.044)
Baseline age, sex, genotyping array, trait-related principal components Only 581 SNPs from the 582 SNP PRS were utilised. 1 SNP was not included due to low imputation quality.
PPM002671 PSS001181|
European Ancestry|
305,471 individuals
PGP000236 |
Ntalla I et al. Nat Commun (2020)
Reported Trait: Non-ischemic cardiomyopathy OR: 0.95
β: -0.051 (0.024)
Baseline age, sex, genotyping array, trait-related principal components Only 581 SNPs from the 582 SNP PRS were utilised. 1 SNP was not included due to low imputation quality.
PPM002672 PSS001182|
European Ancestry|
309,270 individuals
PGP000236 |
Ntalla I et al. Nat Commun (2020)
Reported Trait: Pacemaker OR: 1.06
β: 0.062 (0.016)
Baseline age, sex, genotyping array, trait-related principal components Only 581 SNPs from the 582 SNP PRS were utilised. 1 SNP was not included due to low imputation quality.
PPM002673 PSS001183|
European Ancestry|
309,255 individuals
PGP000236 |
Ntalla I et al. Nat Commun (2020)
Reported Trait: Valve disease OR: 1.03
β: 0.03 (0.013)
Baseline age, sex, genotyping array, trait-related principal components Only 581 SNPs from the 582 SNP PRS were utilised. 1 SNP was not included due to low imputation quality.

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS001175 Cases were individuals with atrial fibrillation. Disease status was ascertained based on data from baseline interviews, hospital diagnosis codes (ICD-9 and ICD-10), cause of death codes (ICD-10), and operation codes. Details of individual selections and disease definitions are described in Supplementary Data 23.
[
  • 14,812 cases
  • , 294,457 controls
]
European UKB
PSS001176 Cases were individuals with atrioventricular preexcitation. Disease status was ascertained based on data from baseline interviews, hospital diagnosis codes (ICD-9 and ICD-10), cause of death codes (ICD-10), and operation codes. Details of individual selections and disease definitions are described in Supplementary Data 23.
[
  • 307 cases
  • , 308,734 controls
]
European UKB
PSS001178 Cases were individuals with distal conduction disease. Disease status was ascertained based on data from baseline interviews, hospital diagnosis codes (ICD-9 and ICD-10), cause of death codes (ICD-10), and operation codes. Details of individual selections and disease definitions are described in Supplementary Data 23.
[
  • 2,789 cases
  • , 287,463 controls
]
European UKB
PSS001179 Cases were individuals with implantable cardioverter defibrillators. Disease status was ascertained based on data from baseline interviews, hospital diagnosis codes (ICD-9 and ICD-10), cause of death codes (ICD-10), and operation codes. Details of individual selections and disease definitions are described in Supplementary Data 23.
[
  • 633 cases
  • , 308,608 controls
]
European UKB
PSS001180 Cases were individuals with mitral valve prolapse. Disease status was ascertained based on data from baseline interviews, hospital diagnosis codes (ICD-9 and ICD-10), cause of death codes (ICD-10), and operation codes. Details of individual selections and disease definitions are described in Supplementary Data 23.
[
  • 529 cases
  • , 308,717 controls
]
European UKB
PSS001181 Cases were individuals with non-ischemic cardiomyopathy. Disease status was ascertained based on data from baseline interviews, hospital diagnosis codes (ICD-9 and ICD-10), cause of death codes (ICD-10), and operation codes. Details of individual selections and disease definitions are described in Supplementary Data 23.
[
  • 1,703 cases
  • , 303,768 controls
]
European UKB
PSS001182 Cases were individuals with a pacemaker. Disease status was ascertained based on data from baseline interviews, hospital diagnosis codes (ICD-9 and ICD-10), cause of death codes (ICD-10), and operation codes. Details of individual selections and disease definitions are described in Supplementary Data 23.
[
  • 3,975 cases
  • , 305,295 controls
]
European UKB
PSS001183 Cases were individuals with valve disease. Disease status was ascertained based on data from baseline interviews, hospital diagnosis codes (ICD-9 and ICD-10), cause of death codes (ICD-10), and operation codes. Details of individual selections and disease definitions are described in Supplementary Data 23.
[
  • 6,244 cases
  • , 303,011 controls
]
European UKB